Rare diseases
Investigational molecules
Locations
A study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.
PolandStudy on the Safety and Effectiveness of Venetoclax with Fludarabine, Amsacrine, and Cytarabine for Patients with MDS, CMML, or Secondary AML Undergoing Stem Cell Transplantation
GermanyStudy on HUVR-CARTemis-1 Therapy for Patients with Relapsed Multiple Myeloma After Allogeneic Transplant Using a Drug Combination
SpainInfusion Study of ARI-0001 Cells for Patients with Resistant or Refractory CD19+ Acute Lymphoid Leukemia
SpainStudy of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease
ItalyStudy on Stopping Allopurinol or Febuxostat in Gout Patients in Remission
FranceStudy on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels
BelgiumStudy of S227928 Alone and with Venetoclax for Patients with Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
FinlandStudy of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome
PolandStudy of ARI-0001 Cells for Children and Adolescents with Resistant or Refractory Acute Lymphoblastic Leukemia
SpainStudy for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination
ItalyStudy on the Safety and Effectiveness of MB-CART2019.1 for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma
CroatiaTell us about your condition – we search every trial in Europe and connect you with the right site.
